Estimating the current burden of Chagas disease in Mexico: A systematic review and meta-analysis of epidemiological surveys from 2006 to 2017

被引:67
作者
Arnal, Audrey [1 ,2 ]
Waleckx, Etienne [2 ,3 ]
Rico-Chavez, Oscar [4 ]
Herrera, Claudia [5 ,6 ]
Dumonteil, Eric [5 ,6 ]
机构
[1] Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Biodiversidad, Mexico City, DF, Mexico
[2] Univ Autonoma Yucatan, Ctr Invest Reg Dr Hideyo Noguchi, Calle 96 S-N X Ave Jacinto Canek y Calle 47, Merida 97225, Yucatan, Mexico
[3] Univ Montpellier, CIRAD, UMR INTERTRYP IRD, Inst Rech Dev, Montpellier, France
[4] Univ Nacl Autonoma Mexico, Fac Med Vet Zootecnia, Dept Etol Fauna Silvestre & Anim Lab, Mexico City 04510, DF, Mexico
[5] Tulane Univ, Dept Trop Med, Sch Publ Hlth & Trop Med, 1440 Canal St, New Orleans, LA 70112 USA
[6] Tulane Univ, Vector Borne & Infect Dis Res Ctr, 1440 Canal St, New Orleans, LA 70112 USA
来源
PLOS NEGLECTED TROPICAL DISEASES | 2019年 / 13卷 / 04期
关键词
TRYPANOSOMA-CRUZI ANTIBODIES; AMERICAN TRYPANOSOMIASIS; BLOOD-DONORS; RURAL-COMMUNITY; PREGNANT-WOMEN; RISK-FACTORS; SEROPREVALENCE; TRANSMISSION; INFECTION; STATE;
D O I
10.1371/journal.pntd.0006859
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background In Mexico, estimates of Chagas disease prevalence and burden vary widely. Updating surveillance data is therefore an important priority to ensure that Chagas disease does not remain a barrier to the development of Mexico's most vulnerable populations. Methodology/Principal findings The aim of this systematic review and meta-analysis was to analyze the literature on epidemiological surveys to estimate Chagas disease prevalence and burden in Mexico, during the period 2006 to 2017. A total of 2,764 articles were screened and 36 were retained for the final analysis. Epidemiological surveys have been performed in most of Mexico, but with variable study scale and geographic coverage. Based on studies reporting confirmed cases (i.e. using at least 2 serological tests), and taking into account the differences in sample sizes, the national estimated seroprevalence of Trypanosoma cruzi infection was 3.38% [95%CI 2.59-4.16], suggesting that there are 4.06 million cases in Mexico. Studies focused on pregnant women, which may transmit the parasite to their newborn during pregnancy, reported an estimated seroprevalence of 2.21% [95%CI 1.46-2.96], suggesting that there are 50,675 births from T. cruzi infected pregnant women per year, and 3,193 cases of congenitally infected newborns per year. Children under 18 years had an estimated seropositivity rate of 1.51% [95%CI 0.77-2.25], which indicate ongoing transmission. Cases of T. cruzi infection in blood donors have also been reported in most states, with a national estimated seroprevalence of 0.55% [95%CI 0.43-0.66]. Conclusions/Significance Our analysis suggests a disease burden for T. cruzi infection higher than previously recognized, highlighting the urgency of establishing Chagas disease surveillance and control as a key national public health priority in Mexico, to ensure that it does not remain a major barrier to the economic and social development of the country's most vulnerable populations.
引用
收藏
页数:19
相关论文
共 72 条
  • [1] Newton-Sánchez OA, 2017, GAC MED MEX, V153, P179
  • [2] [Anonymous], 2015, Wkly Epidemiol Rec, V90, P33
  • [3] [Anonymous], EXP PARASITOL
  • [4] [Anonymous], REV MED I MEX SEGURO
  • [5] [Anonymous], OPSHDMCD42506 OMS
  • [6] [Anonymous], AN MORB INF EP SECR
  • [7] [Anonymous], 2014, PLOS NEGLECT TROP D, DOI DOI 10.1371/journal.pntd.0002776
  • [8] [Anonymous], REV BIOMED
  • [9] [Anonymous], BIOMEDICA
  • [10] Ballinas-Verdugo MA, 2016, REV INVEST CLIN, V68, P286